Compounds > bd 1008
Page last updated: 2024-09-03

bd 1008 and sk&f 10047

bd 1008 has been researched along with sk&f 10047 in 2 studies

Compound Research Comparison

Studies
(bd 1008)		Trials
(bd 1008)		Recent Studies (post-2010)
(bd 1008)		Studies
(sk&f 10047)		Trials
(sk&f 10047)		Recent Studies (post-2010) (sk&f 10047)
2804600

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calderon, SN; Gutkind, JS; Heller, B; Izenwasser, S; Mattson, MV; Newman, AH; Su, TP1
Ablordeppey, SY; el-Ashmawy, MB; Fischer, JB; Glennon, RA; Howie, KB; Ismaiel, AM1

Other Studies

2 other study(ies) available for bd 1008 and sk&f 10047

ArticleYear
Novel 1-phenylcycloalkanecarboxylic acid derivatives are potent and selective sigma 1 ligands.
    Journal of medicinal chemistry, 1994, Jul-22, Volume: 37, Issue:15

    Topics: Animals; Anticonvulsants; Antitussive Agents; Binding Sites; Cyclopentanes; In Vitro Techniques; Male; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Receptors, sigma; Structure-Activity Relationship

1994
Structural features important for sigma 1 receptor binding.
    Journal of medicinal chemistry, 1994, Apr-15, Volume: 37, Issue:8

    Topics: Alkylation; Amines; Animals; Binding Sites; Brain; Cell Membrane; Cyclization; Guinea Pigs; Methylation; Molecular Structure; Receptors, sigma; Stereoisomerism; Structure-Activity Relationship

1994